Hayward, CA, United States of America

Xiaoxia Zhang

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Xiaoxia Zhang: A Pioneer in IDO Inhibition

Introduction:

Xiaoxia Zhang, hailing from Hayward, California, is an innovative inventor who has made significant contributions to the field of pharmaceuticals and immunotherapy. With a total of four patents under his belt, Xiaoxia Zhang has revolutionized the development of IDO inhibitors, providing new possibilities for treating various medical conditions. Let us delve deeper into his groundbreaking work and notable achievements.

Latest Patents:

Xiaoxia Zhang's most recent patents focus on IDO inhibitors and pharmaceutical compositions. These inventions offer a novel approach to modulating the activity of indoleamine 2,3-dioxygenase (IDO) and have far-reaching applications. The patents are aimed at treating IDO-mediated immunosuppression, enhancing the effectiveness of anti-cancer treatments, and addressing tumor-specific immunosuppression associated with cancer. Additionally, Zhang's patents also propose potential treatments for immunosuppression linked to infectious diseases.

Career Highlights:

Xiaoxia Zhang is a key member of the esteemed Newlink Genetics Corporation, a prominent biopharmaceutical company that aims to improve the lives of patients through innovative immunotherapies. His work at Newlink Genetics Corporation has been instrumental in advancing the understanding and application of IDO inhibition in the field of immunotherapy.

Collaborations:

Throughout Xiaoxia Zhang's career, he has had the privilege of working alongside renowned scientists in the pharmaceutical industry. Notably, Zhang has collaborated with Mario Mautino and Sanjeev Kumar, further enriching his research and exploring new avenues for IDO inhibition. These collaborations have undoubtedly contributed to the advancement of novel treatment options and garnered attention within the industry.

Conclusion:

Xiaoxia Zhang's contributions to the development of IDO inhibitors have opened up exciting possibilities for treating immunosuppression and advancing cancer therapies. With his latest patents showcasing the potential of IDO inhibition in a wide range of medical conditions, Zhang's work is undoubtedly making a difference in the field of pharmaceuticals. As he continues to innovate and collaborate with prominent figures in the industry, we can expect even greater advancements in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…